Scotia Capital Inc. Theratechnologies Inc. Transaction History

Scotia Capital Inc.

  • $17.8 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 05, 2022
SELL
$2.21 - $2.7 $3,816 - $4,662
-1,727 Reduced 12.45%
12,150 $27,000
Q1 2022

May 09, 2022
SELL
$2.37 - $3.24 $647 - $884
-273 Reduced 1.93%
13,877 $34,000
Q4 2021

Feb 11, 2022
BUY
$2.92 - $3.76 $41,318 - $53,204
14,150 New
14,150 $43,000

Others Institutions Holding THTX

# of Institutions
1
Shares Held
29.2K
Call Options Held
0
Put Options Held
0
View Full List

About Theratechnologies Inc.

THTX Quotes by TradingView
  • Ticker THTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 95,141,600
  • Market Cap $114M
  • Description
  • Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with l...
More about THTX
Track This Portfolio

Track Scotia Capital Inc. Portfolio

Follow Scotia Capital Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Scotia Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Scotia Capital Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email